ADA 2023

Rodica Pop-Busui, M.D., Ph.D., sits on the panel kicking off the 83rd Scientific Sessions with former NIH Director Francis Collins M.D., Ph.D. (left of her), National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) Director Griffin Rodgers, M.D. (immediate right), and NIDDK Division of Diabetes, Endocrinology and Metabolic Disease Director William Cefalu, M.D. (far right).

Teresa Jones, M.D., Program Director: Division of Diabetes, Endocrinology, & Metabolic Diseases, joins Dr. Pop-Busui to speak about the NIH Diabetes Foot Consortium

Members of the 2023 NIH Diabetes Foot Consortium

Dr. Pop-Busui gives her presidential address

Dr. Pop-Busui sets the new ADA research priorities, including "improving the health of women with diabetes"

A well-deserved standing ovation after Dr. Pop-Busui's speech

Drs. Bruce Perkins and Pop-Busui celebrating the 40th Anniversary of the DCCT/EDIC findings that changed the course of diabetes care